2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average ( ^DJI 0.78%) had just a ...

The Dow Jones rose Wednesday on President Trump's $500 billion Stargate AI project. Netflix stock soared 14% on earnings.

Johnson & Johnson stock gapped down Wednesday after the health care giant issued light 2025 sales guidance, taking a hit from exchange rates.

The Dow Jones and other indexes jumped in the stock market today as investors await Inauguration Day on Monday. Bitcoin ...

A second Dow Jones stock that can be confidently bought in the new year is healthcare conglomerate Johnson & Johnson (NYSE: ...

Chairman Tim Martin said Wednesday that forecasting was more difficult due to increased costs but that the company remained confident of a reasonable outcome for the year. J.D. Wetherspoon expects ...

Intra-Cellular Therapies stock leapt more than 30% Monday morning, after Johnson & Johnson agreed to buy the ...

Stocks were mostly higher on Tuesday, overcoming a bumpy session ahead of tomorrow's consumer price index. The S&P 500 rose 0.1%. The Nasdaq Composite was down 0.2%. The Dow rose 221 points, or 0.5%.

Johnson & Johnson reported better-than-expected quarterly revenue and profit on higher sales of cancer drugs and some medical devices. But shares slipped 3.2% to $143.35 in Wednesday morning trading, ...

The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...

The Dow was crushing the other major indexes to start the day on Monday. The blue-chip index was up 200 points, or 0.5%, while the S&P 500 was down 0.5%. The Nasdaq Composite was down 1.2%. The Dow ...

Dow stocks generally aren’t cheap for a reason ... Medicare’s first price negotiations will begin this year, and J&J’s Stelara, Xarelto and Imbruvica (which it markets with AbbVie [ABBV ...